Cosmo Pharmaceuticals N.V. (LON:0RGI)
63.60
+2.60 (4.26%)
At close: Jul 24, 2025
Cosmo Pharmaceuticals Employees
Cosmo Pharmaceuticals had 322 employees as of December 31, 2024. The number of employees decreased by 3 or -0.98% compared to the previous year.
Employees
322
Change (1Y)
-3
Growth (1Y)
-0.98%
Revenue / Employee
485.22K GBP
Profits / Employee
159.70K GBP
Market Cap
935.53M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 322 | -3 | -0.98% |
Dec 31, 2023 | 325 | 30 | 10.17% |
Dec 31, 2022 | 295 | 5 | 1.72% |
Dec 31, 2021 | 290 | 25 | 9.43% |
Dec 31, 2020 | 265 | 31 | 13.25% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |
Cosmo Pharmaceuticals News
- 4 months ago - Cosmo Pharmaceuticals ernennt neuen Chief Legal Counsel - Cash
- 4 months ago - Cosmo Pharmaceuticals reports FY results - Seeking Alpha
- 5 months ago - Cosmo Pharmaceuticals NV (CMOPF) (FY 2024) Earnings Call Highlights: Record Revenues and ... - GuruFocus
- 5 months ago - Full Year 2024 Cosmo Pharmaceuticals NV Earnings Call Transcript - GuruFocus
- 7 months ago - Cosmo Pharmaceuticals estimates 186% Y/Y growth in 2024 revenue - Seeking Alpha